Innovative approaches to treat steroid-resistant or steroid refractory GVHD
- PMID: 18978736
- DOI: 10.1038/bmt.2008.294
Innovative approaches to treat steroid-resistant or steroid refractory GVHD
Abstract
First-line treatment of GVHD is based on steroids and produces sustained responses in 50-80% of patients with acute GVHD (aGVHD) and 40-50% of patients with chronic GVHD (cGVHD) depending on the initial disease severity. Non-responding children are offered second-line therapy with combinations of various agents, but currently available agents have not improved survival in these high-risk populations. In this minireview, we will focus on new agents to treat GVHD in paediatric patients.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources